Table 1 Clinical characteristics of patients with GPs
Clinical parameters | Malignant (n = 45) | Benign (n = 68) | p value |
|---|---|---|---|
Age | < 0.001 | ||
< 60 | 13 (28.89) | 44 (64.71) | |
≥ 60 | 32 (71.11) | 24 (35.29) | |
Gender | 0.438 | ||
Male | 14 (31.11) | 26 (38.24) | |
Female | 31 (68.89) | 42 (61.76) | |
BMI | 0.098 | ||
< 24 | 25 (55.56) | 27 (39.71) | |
≥ 24 | 20 (44.44) | 41 (60.29) | |
Symptoms | 0.344 | ||
Yes | 33 (73.33) | 55 (80.88) | |
No | 12 (26.67) | 13 (19.12) | |
WBC | 5.56 ± 1.74 | 6.01 ± 2.70 | 0.325 |
Neutrophil | 4.52 ± 6.98 | 3.63 ± 2.54 | 0.337 |
Lymphocyte | 1.62 ± 0.55 | 1.89 ± 0.62 | 0.016 |
Monocyte | 0.36 ± 0.11 | 0.36 ± 0.16 | 0.755 |
PLT | 201.47 ± 71.65 | 217.32 ± 61.55 | 0.212 |
NLR | 0.006 | ||
≤ 1.45 | 6 (13.33) | 25 (36.76) | |
> 1.45 | 39 (86.67) | 43 (63.24) | |
MLR | < 0.001 | ||
≤ 0.24 | 24 (53.33) | 57 (83.82) | |
> 0.24 | 21 (46.67) | 11 (16.18) | |
PLR | 0.087 | ||
≤ 145.69 | 30 (66.67) | 55 (80.88) | |
> 145.69 | 15 (33.33) | 13 (19.12) | |
SIRI | 0.002 | ||
≤ 0.922 | 29 (64.44) | 60 (88.24) | |
> 0.922 | 16 (35.56) | 8 (11.76) | |
TBil | 12.00 (9.50, 15.30) | 12.10 (9.28, 16.02) | 0.826 |
TBA | 4.60 (2.60, 7.00) | 3.90 (2.82, 5.30) | 0.333 |
ALB | 41.05 ± 4.59 | 43.72 ± 3.40 | 0.001 |
ALT | 16.00 (13.00, 25.00) | 15.50 (12.00, 24.00) | 0.372 |
AST | 17.00 (14.00, 20.00) | 16.00 (14.00, 19.25) | 0.275 |
CEA | 2.10 (1.30, 3.10) | 1.70 (1.10, 3.02) | 0.249 |
CA19-9 | 12.00 (9.00, 18.90) | 7.60 (4.35, 15.45) | 0.008 |